Citadel Advisors’s Achaogen Inc AKAO Stock Holding History

Citadel Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,300	Closed	-$10K	–	10330
2019 Q1	$10K	Sell	22,300 -122,300	-85%	-$128K	﹤0.01%	9153
2018 Q4	$178K	Buy	144,600 +21,300	+17%	+$56.9K	﹤0.01%	7951
2018 Q3	$492K	Sell	123,300 -198,900	-62%	-$1.2M	﹤0.01%	6733
2018 Q2	$2.79M	Buy	322,200 +260,900	+426%	+$3.18M	﹤0.01%	3590
2018 Q1	$794K	Buy	61,300 +2,600	+4%	+$29.5K	﹤0.01%	5152
2017 Q4	$630K	Buy	58,700 +25,200	+75%	+$316K	﹤0.01%	5329
2017 Q3	$534K	Buy	33,500 +15,400	+85%	+$293K	﹤0.01%	5231
2017 Q2	$393K	Buy	18,100 +1,100	+6%	+$25.1K	﹤0.01%	5481
2017 Q1	$429K	Buy	+17,000	New	+$349K	﹤0.01%	5278

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors's AKAO Position: Q2 2019 in Review

Citadel Advisors sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 40,659 shares — an estimated $18K sold.

Citadel Advisors first reported a position in AKAO in Q1 2015 and held it in 10 quarters. The position peaked at $18.8M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

Citadel Advisors reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
Citadel Advisors sold 40,659 Achaogen Inc shares in Q2 2019, an estimated $18K.
Citadel Advisors first reported a position in Achaogen Inc in Q1 2015 and held it in 10 quarters.
Citadel Advisors's Achaogen Inc position peaked at $18.8M in Q2 2017.
8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.